ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1099

Age-Specific Estimated Glomerular Filtration Rate for Mortality Prediction in the Korean Population: A Retrospective Kangbuk Samsung Health Cohort Study

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Lee, Kyu-Beck, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Yang, Jihyun, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
  • Hyun, Young Youl, Kangbuk Samsung Hospital, Jongno-gu, Seoul, Korea (the Republic of)
Background

With the advance of the glomerular filtration rate (GFR) formula and the recognition of age-related variations, there is a concern regarding the need to reconsider/adapt a distinct GFR equation for the elderly. We conducted a comparative analysis of the predictive accuracy of CKD-EPI 2009, 2021 (race-free) and the European Kidney Function Consortium (EKFC) equation for mortality prediction across different age groups.

Methods

We analyzed 670,320 participants who underwent a comprehensive health examination, enrolled in Kangbuk Samsung Health Cohort from January 1, 2002 to December 31, 2019 and followed them up for mortality until December 2019. The age group was divided from 18 to 39, 40-64, and over 65 years old (group 1,2,3).

Results

The participants’ median follow-up period was 8.8 years, mean age was 39.8 years old (minimum 18, maximum 97), and 53.6% were male. Mean eGFR using 2009 CKD-EPI was 95.1 ml/min/1.73m2, 100.6 ml/min/1.73m2 using 2021 CKD-EPI, 94.0 ml/min/1.73m2 using EKFC. There was no difference between the equations in group 1. Discriminatory power for all-cause mortality prediction was the best when using EKFC in group 2 and group 3. Moreover, the EKFC showed better discriminatory power for CVD mortality in all age groups.

Conclusion

The EKFC equation showed better prediction and explanation in middle age to the elderly.